How to design the surface of peptide-loaded nanoparticles for efficient oral bioavailability?

被引:84
作者
Malhaire, Helene [1 ,2 ]
Gimel, Jean-Christophe [1 ,2 ]
Roger, Emilie [1 ,2 ]
Benoit, Jean-Pierre [1 ,2 ]
Lagarce, Frederic [1 ,2 ,3 ]
机构
[1] INSERM U1066 Micro & Nanomed Biomimet, Angers, France
[2] Univ Angers, Angers, France
[3] Angers Univ Hosp, Dept Pharm, Angers, France
关键词
Protein and peptide drugs; Nanoparticle; Specific surface area; Protein corona; Mucus interaction; SOLID LIPID NANOPARTICLES; WHEAT-GERM-AGGLUTININ; INSULIN DELIVERY-SYSTEMS; HUMAN CERVICAL-MUCUS; IN-VIVO EVALUATION; MEDIATED DRUG-DELIVERY; WATER-SOLUBLE DRUG; INTESTINAL-ABSORPTION; P-GLYCOPROTEIN; MUCOADHESIVE POLYMERS;
D O I
10.1016/j.addr.2016.03.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The oral administration of proteins is a current challenge to be faced in the field of therapeutics. There is currently much interest in nanocarriers since they can enhance oral bioavailability. For lack of a clear definition, the key characteristics of nanoparticles have been highlighted. Specific surface area is one of these characteristics and represents a huge source of energy that can be used to control the biological fate of the carrier. The review discusses nanocarrier stability, mucus interaction and absorption through the intestinal epithelium. The protein corona, which has raised interest over the last decade, is also discussed. The universal ideal surface is a myth and over-coated carriers are not a solution either. Besides, common excipients can be useful on several targets. The suitable design should rather take into account the composition, structure and behavior of unmodified nanomaterials. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:320 / 336
页数:17
相关论文
共 264 条
[51]   TEMPORARY OBSTRUCTIVE EFFECT OF HUMAN CERVICAL-MUCUS ON SPERMATOZOA THROUGHOUT REPRODUCTIVE LIFE - SCANNING ELECTRON-MICROSCOPIC STUDY [J].
CHRETIEN, FC ;
DAVID, G .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1978, 8 (06) :307-321
[52]   Thiolated carboxymethylcellulose:: in vitro evaluation of its permeation enhancing effect on peptide drugs [J].
Clausen, AE ;
Bernkop-Schnürch, A .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2001, 51 (01) :25-32
[53]   Barrier properties of mucus [J].
Cone, Richard A. .
ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (02) :75-85
[54]  
Cosgrove T., 2010, COLLOID SCI, V2nd
[55]   Barrier Properties of Gastrointestinal Mucus to Nanoparticle Transport [J].
Crater, Jason S. ;
Carrier, Rebecca L. .
MACROMOLECULAR BIOSCIENCE, 2010, 10 (12) :1473-1483
[56]   Mucus permeating carriers: formulation and characterization of highly densely charged nanoparticles [J].
de Sousa, Irene Pereira ;
Steiner, Corinna ;
Schmutzler, Matthias ;
Wilcox, Matthew D. ;
Veldhuis, Gert J. ;
Pearson, Jeffrey P. ;
Huck, Christian W. ;
Salvenmoser, Willi ;
Bernkop-Schnuerch, Andreas .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 97 :273-279
[57]   Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier [J].
de Sousa, Irene Pereira ;
Cattoz, Beatrice ;
Wilcox, Matthew D. ;
Griffiths, Peter C. ;
Dalgliesh, Robert ;
Rogers, Sarah ;
Bernkop-Schnuerch, Andreas .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 97 :257-264
[58]   An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells [J].
des Rieux, Anne ;
Fievez, Virginie ;
Theate, Ivan ;
Mast, Jan ;
Preat, Veronique ;
Schneider, Yves-Jacques .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 30 (05) :380-391
[59]   Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach [J].
des Rieux, Anne ;
Fievez, Virginie ;
Garinot, Marie ;
Schneider, Yves-Jacques ;
Preat, Veronique .
JOURNAL OF CONTROLLED RELEASE, 2006, 116 (01) :1-27
[60]   Gastrointestinal uptake of biodegradable microparticles: Effect of particle size [J].
Desai, MP ;
Labhasetwar, V ;
Amidon, GL ;
Levy, RJ .
PHARMACEUTICAL RESEARCH, 1996, 13 (12) :1838-1845